Showing results (81-90 of 267) with videos related to
Sort By:
Pageof 27
Die Pharmazie|June 1, 1987
[The effect of ion pair formation on the pharmacokinetics of drugs. 2. The effect of hexylsalicylic acid on the pharmacokinetics of quinine]R Neubert, W Fürst, P Schulze, et al.The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Transport characteristics of differently charged cephalosporin antibiotics in oocytes expressing the cloned intestinal peptide transporter PepT1 and in human intestinal Caco-2 cellsU Wenzel, I Gebert, H Weintraut, et al.Frontiers in Microbiology|September 14, 2012
Challenges and opportunities in estimating viral genetic diversity from next-generation sequencing dataNiko Beerenwinkel, Huldrych F Günthard, Volker Roth, et al.Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|May 1, 1980
[Clinico-pharmacological investigation of an oral form of a depot preparation on silicone resin base with indomethacin as the active ingredient]J Metzner, H Bekemeier, H Kala, et al.Journal of Medicinal Food|September 24, 2005
A new Coenzyme Q10 tablet-grade formulation (all-Q) is bioequivalent to Q-Gel and both have better bioavailability properties than Q-SorBU Ullmann, J Metzner, C Schulz, et al.Thrombosis and Haemostasis|November 2, 2013
Extending the pharmacokinetic half-life of coagulation factors by fusion to recombinant albuminH J Metzner, S W Pipe, T Weimer, et al.Nucleic Acids Research|January 17, 2022
Structural and biochemical characterization of human Schlafen 5Felix J Metzner, Elisabeth Huber, Karl-Peter Hopfner, et al.Molecular Biology and Evolution|June 29, 2019
Parallel Evolution of HIV-1 in a Long-Term ExperimentFrederic Bertels, Christine Leemann, Karin J Metzner, et al.Plos Biology|December 28, 2020
Long-term experimental evolution of HIV-1 reveals effects of environment and mutational historyEva Bons, Christine Leemann, Karin J Metzner, et al.Molecular Therapy. Methods & Clinical Development|July 7, 2022
Quantification of transgene expression in GSH AAVS1 with a novel CRISPR/Cas9-based approach reveals high transcriptional variationAnne Inderbitzin, Tom Loosli, Roger D Kouyos, et al.Pageof 27